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The problem. A patient, KB, diagnosed with the 
autosomal recessive genetic disorder Bloom Syndrome on the 
basis of clinical features, had failed to display the 
characteristic cytogenetic features of the syndrome. This 
research compared the growth response to bovine pituitary 
fibroblast growth factor, the mitotic index, and the sister 
chromatid exchange level of the KB fibroblasts with normal 
and known Bloom Syndrome control fibroblasts. 
Procedure. The growth responses of the KB, normal, and 
Bloom Syndrome cell lines to fibroblast qrowth factor were 
determined by culturing the fibroblasts over a seven-day 
period in the presence of three concentrations of fibroblast 
growth factor in medium supplemented with two levels of 
fetal bovine serum. Cell concentrations were measured at 
regular intervals over the culture period using a Coulter 
counter. Sister chromatid exchange levels were determined 
by culturing the fibroblasts for 72 hours in medium 
supplemented with the thymidine analog 5-bromo-2'- 
deoxyuridine. Following culture, cells were harvested and 
stained for differentiation of the sister chromatids using a 
fluorescence plus Giemsa technique, A mitotic index for 
each cell line was determined by counting the number of 
cells in division per 1000 cells on the slides prepared for 
sister chromatid exchange analysis. 
Findings. Like the normal cells, the KB fibroblasts 
utilized fibroblast growth factor for growth based on 
measurements of the population doubling time in the first 48 
hours of culture. Unlike either of the control cell lines, 
however, the KB fibroblasts exhibited no response to 
fibroblast growth factor as measured by maximum cell 
concentration attained. The mitocic index for the KB cell 
line was considerably lower than that determined for either 
control line. The sister chromatid exchange level seen in 
the KB fibroblasts corresponded with that seen in the normal 
control fibrobLasts and was unlike the elevated level seen 
in the Bloom Syndrome cells. 
Conclusion. The diagnosis of Bloom Syndrome in the 
patient, KB, is not supported an the basis of the growth 
responses of the patient's fibroblasts to fibroblast growth 
factor, the mitotic index, and the sister chromatid exchange 
rate. 
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INTRODUCTION 
Bloom Syndrome: Features-. Bloom Syndrome (BS) is a 
rare autosomal recessive genetic disorder that is 
characterized by both clinical and cytogenetic features. 
First identified as a syndrome by Dr. David Bloom in 1954 
(Bloom 19541, the disorder has become a model for the study 
of growth, carcinogenesis, and the mechanisms of sister 
chromatid exchange (Passarge 1983). 
Clinical features of BS include pre- and postnatal 
growth retardation that results in proportional dwarfism; a 
telangiectatic erythema consisting of a butterfly-shaped 
rash on the face; dolichocephaly, with an elongated 
characteristic facial appearance; immunodeficiency; and a 
predisposition to the development of cancers (Passarge 1983; 
Kaiser-McGaw 1982; Schroeder 1982). BS patients typically 
have normal intelligence. Other, more variable, symptoms 
include hypogonadism, and the appearance of "twin spots", 
adjacent areas of hyper- and hypopigmentation. A variety of 
additional congenital malformations occur with a slightly 
higher frequency in BS, but there is no pattern. Such 
abnormalities include congenital heart disease, annular 
pancreas, abnormal thumb, absent toe, and cryptorchidism. 
Many BS individuals have poor speech development, with high- 
pitched, squeaky voices. They may also exhibit 
characteristic behavior patterns such as restlessness, 
irritability, and lack of concentration (Passarge 1983). 
Increased endocrinopathy and muscle weakness with age have 
also been reported (Ahmad et al. 1977). Growth retardation 
is perhaps the most important clinical feature of the 
disease (German et al. 1979). Birth size is small, with a 
mean birth weight of 1960 g (vs. a normal mean birth weight 
of 2500 g) and average length at birth is 44 cm (vs. a 
normal average Length of 50 cm). Growth is below the third 
percentile throughout childhood, but the rate of growth is 
comparable to normal; however, a growth spurt before puberty 
is lacking or minimal in BS individuals (Passarge 1983) . 
Average adult height of BS patients is 4 ' 9 "  with normal body 
proportions. Sun sensitivity is a hallmark of the disorder, 
but skin areas other than the face, hands, and forearms are 
not unduly sensitive to sunlight and lesions produced in 
sensitive areas may show improvement with age. Skin lesions 
typically are less severe in females. This variability in 
skin sensitivity has made some cases of BS difficult to 
diagnose (Vanderschueren-Lodeweyckx e t  al. 1984). The 
characteristic immunodeficiency results from a decrease in 
the serum concentration in at least one class of 
immunoglobins (IgG, IgA, or IgMf, with BS patients 
exhibiting weak levels of humoral and cellular responses 
after antigenic challenge {Weameas et al. 1979; ~aniguchi e t  
al. 1 9 8 2 ) .  Bloom Syndrome infants frequently suffer from 
feeding problems, and upper respiratory tract infections are 
common in BS children as a result of this immunodeficiency. 
Cancer was first recognized by James German (1969) as 
being more prevalent in Bloom Syndrome patients. 
Approximately one cancer has occurred for every four persons 
diagnosed with BS since the syndrome was first described, 
with acute leukemia being the most common neoplasm (6erman 
1980). Cancer in Bloom Syndrome is impressive in three 
ways: by the frequency of its occurrence, by the diversity 
of its type, and for the unusually early age of onset. Many 
of the cancers that occur with regularity in the general 
population just occur more commonly in BS and at an earlier 
age, Cancer deaths are over two times greater in BS 
individuals than in the general population: therefore, Bloom 
Syndrome is considered a cancer-prone syndrome. 
In 1965 the first chromosome analysis was performed 
an the lymphocytes of a BS patient (German et al. 1965). 
This led to the discovery of the characteristic chromosome 
ility now associated with the disorder and opened the 
cytogenetic analysis of Bloom Syndrome. 
is now known as one of the *chromosome- 
s " ,  a term coined by James German in 1965 
1965) to draw attention to those disorders in 
cyte cultures show an abnormally high 
1 chromosome aberrations. Cytogenetic 
features seen in Bloom Syndrome include an increased number 
of chromosome breaks, gaps, and rearrangements, the presence 
of quadriradial configurations, and a greatly increased 
frequency of spontaneous sister chromatid exchange (SCE) 
(Chaganti et al. 1974, German et al. 1977a). Signs of 
chromosome breakage and reunion are evident in 5-15% of BS 
metaphases (Ray and German 1983) and quadr iradial exchange 
formations between homologous chromosomes are seen in 
approximately 1% of BS metaphases (Passarge 1983). It is 
the elevated sister chromatid exchange level, however, that 
is the most important cytogenetic feature of the disease, as 
Bloom Syndrome is the only known genetic disorder in which 
the level of SCE is increased spontaneously, Normal cells 
show an average of 6.9 SCE's per metaphase, whereas in Bloom 
Syndrome cells, the SCE level is increased ten- to 
f ifteenfold, for an average of 60-80 SCE% per metaphase 
(Chaganti et al. 1974; Bartram et al. 1975; German et al. 
1977a; Dicken et al. 1978). These SCE's, as well as any 
chromosome breaks or gaps, occur in all regions of the 
genome and they are seen in all tissues (lymphocytes, 
fibroblasts, and bone marrow) (Ray and German 1983). The 
elevated SCE level has become such a hallmark of the 
disorder that it is now considered necessary to confirm the 
diagnosis of Bloom Syndrome (German et a l .  1977a). 
In 1965, the ~endelian basis of inheritance of Bloom 
Syndrome was established (German et al. 1965). The 
autosomal recessive nature of the disorder was suggested by 
the observations of German and co-workers that in some 
families more than one sibling was affected; that several 
incidences of consanguineous parentage were recorded; and 
about half the known cases were in Ashkenazi Jews with 
recent ancestry in the central European area. Following 
this mode of inheritance, the offspring from the union of 
heterozygotes for the mutant BS gene would have a 25% risk 
of having BS. Since its description more than 30 years ago, 
Bloom Syndrome has been diagnosed in over 100 persons, It 
has been observed in different parts of the world and in 
different ethnic groups, but remains rare except in the 
Ashkenazi Jewish population, which has been estimated to 
have a heterozygote frequency of 1:120 (German et al. 1977b, 
German et al. 1984)- The sex ratio of males to females in 
BS is 1.4:1 (German et al. 1984). The reason for this 
imbalance is unknown: however, underdiagnosis in females is 
postulated. The current Bloom Syndrome population as a 
whole has a mean age of 18.2 years (range: 4-37). It is 
thought that this mean population age may be lowered by 
immunodeficiency as well as by the attrition rate through 
cancer deaths (German et al. 1984) . 
Hypermutability in Bloom Syndrome. The question of 
genetic heterogeneity remains unanswered in Bloom Syndrome, 
with no strong clinical or experimental evidence to support 
it. An unexpected and interesting finding in Bloom Syndrome 
research, however, has been the identif ieation of two 
lymphocyte populations with respect to sister chromatid 
exchange in some BS individuals, in which the larger 
population displays the characteristic elevated SCE level, 
but a minor population (ranging from a few cells to 47%) 
shows SCE" in the normal range (German et al. 1977a; 
Shiraishi et al. 1983b). This dimorphism is not seen in 
dermal fibroblasts or in bone marrow, but has been seen in 
lymphoblastoid cell lines derived from single B lymphocytes 
(Shiraishi et al. 1983a)- Such cell lines have either a 
normal or an elevated SCE rate and imply the existence of 
two cell populations in vivo. The reason for the two 
populations is unclear. It has been postulated that a back 
mutation has occurred at a BS locus which could restore 
normal gene function in one BS allele, giving rise to a 
heterozygous condition in that particular clonal line. The 
support for this comes from two in vitro studies (Warren et 
al. 1981: Vijayalaxmi et al. 1983) that indicate that 
spontaneous mutation frequency in BS fibroblasts may be ten 
times greater than in normal fibroblasts. Evidence also 
points toward a marked elevation in the in vivo spontaneous 
mutation rate in BS PHA-stimulated lymphocytes (Ray and 
German 19831, lending further support. Warren et al. 119811 
tested BS cells and found them to be spontaneously 
hypermutable. They showed BS fibroblasts to have an 
increase in the rate of spontaneocs mutation at the HGPRT 
locus five to ten times that of control fibroblasts, and 
postulated that BS may be a mutator mutation, a mutation at 
a locus which maintains the rate of spontaneous mutation at 
an acceptably low level (Warren 1981). Such a phenomenon, 
seen in many organisms, is previously unrecognized in 
humans. Warren suggested that this possible mutator 
activity in BS can be correlated with the low birth weight 
and small stature in Bloom Syndrome individuals as the rate 
of growth fundamentally is determined by cell number. Cell 
loss, slow mitotic rate, or both, could account for these 
symptoms. 
Theories on the oriqin of neoplasia in Bloom 
Syndrome. It is suggested that the increase in the 
incidence of malignancy in BS individuals could be explained 
by the somatic mutation theory of cancer (Warren 1981). 
Most human neoplasms consist of clonal proliferations of 
cells with chromosome abnormalities, Such chromosome 
abnormalities have Seen shown to be caused by environmental 
agents which cause cancer and are known to occur 
spontaneously in Bloom Syndrome cells. Currently held v i e w s  
of mutation describe gene mutations and chromosome mutations 
(aberrations) as the ends of a common spectrum of genetic 
instability (Chaganti 1983). If chromosome breaks represent 
one point on such a spectrum, then the spontaneous mutation 
rate would be expected ta be elevated in BS cells, a 
prediction which has been demonstrated. Warren 41981) 
proposes that in a hypermutable system such as Bloom 
Syndrome, enhanced mutation is the pathway to malignancy 
and, in general, can serve as a model for the origin of 
neoplasia. In Bloom Syndrome it is interesting to note that 
the majority of cancers are found in rapidly dividing 
tissues such as bone marrow and the GI tract (German 
1983a). Inasmuch as the yield of spontaneous mutants is 
correlated with the number of cell divisions, this is as 
expected, as one would find the greatest number of cancers 
in those cells with the highest frequency of mutations. 
Transformation experiments, however, have failed to fend 
support to this theory, Bloom Syndrome cells are 
surprisingly less prone to viral transformation (Lin and 
Alfi 1980) and have shown no correlation between 
transformation and chromosome aberrations (Webb and Harding 
1977 ;  Lin and Alfi 1980; Shiraishi et al. 1983a), suggesting 
that chrsmosorne aberrations are not directly related to the 
high cancer risk. Somatic cell recombination has also been 
proposed as a mechanism to explain the increased evidence of 
neoplasia in Bloam Syndrome. This theory holds that a cell 
that contains a mutation at just one allele can, through 
somatic recombination, become homomygous for that mutation, 
and that in BS, twin spots may be a manifestation of just 
such an event (Festa et al. 1979; German 1983a). This 
supports the idea that cancer may be a recessive disorder at 
the cellular level, 
Sensitivities of Bloom Syndrome cells. Bloom 
Syndrome cells, like normal cells, are sensitive to various 
mutagens in vitro, but the only hypersensitivities 
determined so far for BS cells are to ethylating agents such 
as ethyl methanesulfonate (EMS), as measured by SCE 
induction (Krepinsky et al. 1979) and to mitomycin C (PIIMC) 
as measured by cell death (Book et al. 1984). Krepinsky et 
al. (1979, 1982) showed that the ethylating agent EMS 
induced six times more SCEfs in BS lymphocytes than in 
normal or BS heterozygote lymphocytes at an EMS 
concentration of 3 x 10-4 M, In BS individuals with two 
lymphocyte populations, only the population with a high SCE 
frequency showed an increased sensitivity to EMS. EMS has 
no abnormal effect on BS cells with respect to cell death 
(Book et ale 1984). This is the converse of the reactions 
of BS cells to the bifunctional alkylating agent mitomycin 
C ,  in which recent studies show a 55% increase in MMC- 
induced cell death of BS cells, but no hypersensitivity with 
respect to sister chromatid exchange (Hook et al. 1984). 
Earlier research concerning mc-induced SGE in Bloom 
Syndrome cells was contradictory. As MMC was shown to cause 
an increase in SCE in BS Cells approximately two times the 
untreated frequency, it was thought that this reflected a 
hypersensitivity. The increase in MMC-induced SGE in normal 
cells, however, was found to be even greater (Shiraishi and 
Sandberg 1978, 1979, 1980), indicating that perhaps the 
effect of MMC was the same on both BS and non-BS cells, with 
the BS cells reaching a saturation Level of SCE. 
With respect to W light, there has been a 
heterogeneity of response, The sensitivity of BS 
fibroblasts varies from strain to strain with exposure to 
far-W light (wavelength below 290 nm) , as measured by cell 
survival (Ishizaki et al. 1981; Hook et aL. 1984), with the 
majority of strains tested showing normal sensitivity 
(Krepinsky et al. 1980). BS fibroblasts exposed to near-W 
light (313 nm), however, have been found to have abnormal 
survival properties (Zbinden and Cerutti 1981) and excessive 
single-strand DNA breakage in six of eight BS strains tested 
(Hirschi et ale 1981). Near-W light sensitivity is a more 
accurate measure of true BS cellular sensitivity under 
natural conditions as far-W light is eliminated from the 
solar spectrum by the upper atmosphere- 
Nature of the defect in Bloom Syndrome. Early 
theories held that Bloom Syndrome was very likely a repair- 
deficient syndrome, as chromosome aberrations, mutagen and 
solar sensitivities, and an increased cancer incidence are 
consistent with defects in DNA repair mechanisms. Research 
has shown, however, that BS cells respond normally in 
excision repair fAhmed and Setlow 1978; Henderson and 
Ribecky 1980f, post-replication repair (~hiraishi and 
Sandberg 1977), and normal repair of single-stranded breaks 
(Vincent et al, 1978; Schonberg and German 1980; Fornace et 
al. 1980) and double-stranded breaks (Hurt et al. 19811, 
The excision repair system was tested fallowing damage by W 
light and N-acetoxy-2-acetylaminofluorene (AAAF) and was 
found to be normal as measured by the rate of unscheduled 
DNA synthesis (UDS) following treatment (Ahmed and Setlow 
1978; Remsen 1 9 8 0 ) .  Research showed that BS fibroblasts had 
higher than normal Levels of UDS (19-29% higher), but that 
the rate of UDS did not differ from that of normal controls 
following exposure to UV radiation (Giannelli et al. 
1981). This finding could be explained by a greater than 
normal number of sites which need to be repaired initially 
on the BS DNA molecule. These researchers also hypothesized 
that BS cells may contain a diffusabfe factor which 
influences at least the initial rate of UDS, as evidenced by 
fusion experiments. The general trend of these studies has 
seemed to indicate that DNA repair is intact in Bloom 
Syndrome. Further efforts to elucidate the basic defect 
have measured the levels of DNA polymerases ( a .  8 ,  and y) 
and apurinic site-specific endonuelease in BS cells and 
found them to be normal (~arker and Lieberman 1977: Moses 
and Beaudet 1978; Bertazonni et al. 1978). It was also 
found that a11 four deoxyribo- nucleoside triphosphate pool 
levels correspond to those of normal controls (Warren 1981). 
Most recent research has focused on the hypothesis 
that Bloom Syndrome is a DNA-replication-deficient syndrome 
(Giannelli et al, 1977). DNA replication in mammalian cells 
is initiated at many different sites on the same molecule in 
units called replicons. Synthesis is bidirectional, 
proceeding outward from each initiation point, an action 
termed replication fork movement. Termination occurs when 
two adjacent replicons join and the daughter DNA molecules 
separate, The DNA replication rate is determined largely by 
two components: the number of actively replicating 
replicons, and the average linear fork movement rate, BS 
cells have shown normal replicon unit length and incidence 
of bidirectional replication (Hand and German 1977; 
Giannelli et al. 1977). Cells from patients with BS, 
however, are apparently the only human cells that have a 
slower than normal replication fork movement rate (German et 
al. 1979; Kapp and Painter 1982). It has been found that 
fork displacement rates in BS cells are approximately 30% 
slower than those in normal cells, with a more severe effect 
seen in lymphocytes than in fibroblasts (Kapp 1982; Hand and 
German 1977)- German et al. (1979) reported that the rate 
of DNA chain maturation in BS cells is lower than that in 
normal cells and many researchers have reported that BS 
fibroblasts grow more slowly than normal fibroblasts 
(Lechner et al. 1983; German et al. 1984). Brat (1979) 
found the BS cell cycle duration to be similar to that of a 
normal cell line, but reported a lowered mitotic index- In 
culture, BS cells have been shown to exhibit less than 1% 
clonal efficiency, in contrast to a greater than 10% clonal 
efficiency for non-BS cultures (German et al. 1984). 
Measuring lifespans of fibroblasts in terms of number of 
passages, Thompson and Holliday (1983) found that BS 
fibroblasts had a lifespan of 27.8 passages, approximately 
half that of controls, This could be due to an impaired 
ability to respond fully to growth stimulation, as evidenced 
by the results of a study of Lechner et al. (1983) in which 
the response of BS cells to epidermal growth factor (EGF)- 
promoting activity was half that of normal cells. Ockey 
(1979), in a contradictory study, looked at the relationship 
between DNA chain growth and the distance between adjacent 
replicons in BS fibroblasts and found the mean rate of chain 
growth was decreased only when cells were grown at a low 
density and concluded that the slow rate of chain growth in 
BS cells is an artifact introduced by culture conditions. 
CO-cultivation and cell hybridization experiments. 
In an attempt to answer the crucial question of whether the 
increased frequency of sister chromatid exchange in BS cells 
is due to the lack of a normal metabolite or the production 
of an abnormal one, the co-cultivation oE BS and non-BS 
cells has been used experimentally. The question is still 
controversial in view of contradictory reports. Tice et al.. 
(1978) maintain that the rate of SCE in normal fibroblasts 
was increased (by 20-50%) above the normal level when co- 
cultivated with BS cells, as was the SCE frequency of PHA- 
stimulated normal human lymphocytes grown in medium 
"conditioned" for 48 hours by proliferating BS 
fibroblasts. They concluded that the chromosome instability 
in Bloom Syndrome results from the over-production of some 
DNA-damaging cellular component, Most attempts to 
corroborate these experiments by Tice et al. have been 
unsuccessful, although Barnabei and Kelly (1982) wrote of 
work corroborating Tice's findings. Emerit and Cerruti 
(1981) reported that greatly concentrated ultrafiltrates of 
BS-conditioned medium had a clastogenic and slightly 
SCE-inducing effect on normal PEA-stimulated lymphocytes. 
Other co-cultivation and conditioned medium experiments have 
yielded data that contrast with that of Tice et al. Van 
B U U ~  et al. (1978) demonstrated the suppression of SCEvs by 
30% in BS fibroblasts upon co-cultivation with Chinese 
hamster ovary (CHO) cells, but only If cell-to-cell contact 
occurred. They reported that the BS cells, in turn, had no 
effect on the CHO cells. Bartram et al. (1979), in the co- 
cultivation of normal and BS fibroblasts, showed a reduction 
of SCE's in the BS cells that was repeated with the use of 
normal-conditioned medium, These results suggest that 
normal cells produce an agent that acts as a corrective 
factor in BS cells, a factor either absent or inactive in 
Bloom Syndrome. These experiments have been duplicated and 
the results corroborated by other researchers (Rudiger et 
al. 1980; Schonberg and German 1980; Bartram et al. 1981). 
It has also been shown that BS heterozygote cells exhibit a 
corrective effect upon co-cultivation with BS homozygote 
cells, although to a lesser capacity, suggesting a gene 
dosage effect (Bartram et al. 1981)- Rudiger (19821, in the 
co-cultivation of BS fibroblasts with normal, xeroderma 
pigmentosum, and Fanconits anemia fibroblasts, produced a 
dose-dependent reduction in Bloom-specific SCE, the rate of 
SCE decreasing linearly with increased portions of non-BS 
cells (while the SCE rates in non-BS cells remained 
unchanged). He related this reduction to a soluble 
corrective factor (M.W. 10,000-20,000) which is produced in 
culture by non-BS proliferating fibroblasts. He postulated 
that this corrective factor may represent a eancer- 
protective principle that is defective in BS individuals and 
noted that the finding of such a factor could be compatible 
with the previous findings of a elastogenic factor in BS 
(Tice et al. 1978) should the defect be due to a genetically 
defective detoxification system. To complicate the matter, 
however, Shiraishi et al. (1981) found the SCE frequencies 
of normal, BS heterozygote, and BS homozygote lymphocytes to 
be unchanged following co-cultivations at 1:l ratios for 24 
hours, and Ray and German (1983) reported that neither 
fibroblasts nor lymphocytes from normal individuals affected 
the SCE rate of BS fibroblasts or lymphocytes, even when co- 
cultivated at a non-BS:BS ratio of 4:l. They also showed 
that normal-conditioned medium was totally ineffective in 
reducing the SGE frequency in BS fibroblasts. The seemingly 
conflicting results of these co-cultivation experiments are 
hard to reconcile, In a series of cell hybridization 
experiments, an extension was seen of the findings of those 
co-cultivation experiments which suggested normal-cell 
production of a BS corrective factor. Complete correction 
of the mutant phenotype was reported, with a reversion of 
SCE's in BS fibroblasts to normal levels when hybridized 
with normal fibroblasts (Bryant et al. 1999; Shiraishi et 
ax. 1981). Alhadeff et al. (1980) showed full correction of 
the elevated SFE level in BS fibroblasts upon hybridization 
with CHO cells, concluding that increased SCE in Bloom 
Syndrome is due to the loss of a normal function that is 
restored by hybridization. 
~etoxification deficiency theory. A current 
hypothesis that would explain the findings of Tice et al. 
(1978) and Emerit and Cerutti (1981) concerning the 
formation of a clastogenic factor (CF) in BS cells is based 
on the suspicion that BS cells are deficient in their 
ability to detoxify active oxygen species. Cerutti (1982) 
noted that some clinical, cellular, and biochemical 
abnormalities in Bloom Syndrome point toward disturbances in 
the formation or the detoxification of active oxygen species 
(superoxide radicals, singlet oxygen, hydroxyl radicals, 
hydrogen peroxide), His research showed that Cu-Zn- 
Superoxide dismutase (Cu-Zn-SOD), an enzyme which catalyzes 
the dismutation of superoxide radicals, strongly inhibits 
the activity of a clastogenic factor from BS fibroblasts. 
In light of this, plus the sensitivity of BS patients and 
their cultured fibroblasts to solar radiation, the increased 
frequency of sister chromatid exchange, and the increased 
cancer incidence, a model was put forth proposing the 
formation of a clastogenic factor by elevated levels of 
active oxygen species in BS cells (Emerit and Cerutti 1981: 
Cerutti 1982). Emerit et al. (1982) showed that the 
generation of superoxide radicals in growth medium increased 
chromosome breakage and SCE rates in human lymphocytes, 
actions which were prevented alrnofit entirely by SOD. Their 
data suggest a role for Superoxide radicals in the origin of 
chromosome mutation, If true, an increase in the 
intracellular concentration of superoxide radicals could 
contribute to chromosome aberrations and a high rate of 
sister chromatid exchange in Bloom Syndrome. The induction 
of SOD is mediated by the substrate, so that an increase in 
SOD activity should reflect an increase in superoxide 
radical concentration. Nicotera et al. (1983) quantitated 
the activities of Mn- and Cu-Zn-SOD in two BS fibroblast 
lines (Mn-SOD is mitochondria1 SOD; Cu-Zn-SOD is cytoplasmic 
SOD) and found a 45% increase in Cu-Zn-SOD activity and a 
125% increase in Mn-SOD activity, They postulated that the 
superoxide radicals responsible for the induction of this 
SOD activity in BS may be at such high Levels that the 
increased SOD was insufficient to detoxify them. There are 
several mechanisms for the formation to active oxygen 
species in mammalian cells, and an abnormality in their 
formation or detoxification would be expected to affect all 
tissues (Cerutti 1 9 8 2 ) .  
Sister chromatid exchanqe, Sister chromatid exchange 
is a reciprocal interchange between DNA replication I?roducts 
that requires a means of differentiation of the sister 
chromatids for detection. The discovery of SCE was made by 
Taylor et a l .  (1957) following the labeling of replicating 
chromosomes with 3~-thymidine and the observation of the 
label's segregation. Taylor showed that when the label was 
incorporated into DNA during the first round of replication 
and analyzed at the second metaphase, the label was observed 
in only one of the sister chromatids of the chromosome. 
This delineation of the two chromatids allowed one to 
observe "occasional chromatid exchangesq' (Taylor et al. 
1957). Taylor concluded from his observations that SCE is a 
double-strand exchange, and that the rejoining of the 
strands is not random, but is restricted to subunits of the 
same polarity. 
Use of the 3~-thymidine label to detect SCE has given 
way to the use of the thymidine a~-alog 5-bromo-2'- 
deoxyuridine (BrdU) as a label, which allows for higher 
resolution compared with autoradiography (Zakharov and 
Egolina 1972). In a variety of techniques, cells are grown 
in the presence of BrdU for two rounds of replication so 
that one chromatid is bifilarly substituted with the analog 
and the sister chromatid is unifilarly substituted. 
Differences in BrdU substitution can then be used to 
differentially stain the chromatids. Latt (1973) reported 
the method of staining chromosomes with the fluorescing 
bisbenzimidazole dye Hoechst 33258 so that the bifilarly 
substituted chromatid quenched the fluorescence to a greater 
extent than did the unifilarly substituted chromatid. The 
procedure most widely used today in the detection of sister 
chromatid exchange is the "fluorescence plus Giemsa EFPG) 
techniquem (Perry and Wolff 1934) in which Hoechst 33258 and 
short-wavelength light are used to treat the chromosomes, 
followed by staining with Giernsa. With this technique, the 
less-substituted chromatid is stained more intensively. 
The observation that a significant portion of SCE's 
are independent of technical factors involved in their 
detection has led to the characterization of SCE's in normal 
cells (Zakharov 1982). A lower level of SCE's in 
heterochromatic regions of the chromosome as compared with 
the euehrornatic regions has been observed (Hsu and Pathak 
1976), and also the nonrandom distribution of SCE's among 
human chromosome groups B, E, F, and G fLatt 1974a). The 
average frequency of sister chromatid exchanges in normal 
cells was found to be 1025 (Morgan and Crossen 1977). 
Chaganti et al. (1974) were the first to show a manyfold 
increase in the SCE levels in cells of Bloom Syndrome 
individuals above this baseline rate, Pioneering work by 
Latt (1974b) showed SCE as a sensitive indicator of 
mitomycin C damage in cells. Further research has shown 
that SCE's are produced by the majority of mutagenic 
carcinogens, although they have yet to be quantitatively 
correlated with mutations (Stetka 198 2 )  . Never theless, 
SCE1s are apparently manifestations of the interactions of 
chemical or physical agents with a cell's DMA, and research 
has expanded to the extent that now sister chromatid 
exchange is used extensively as a sensitive test for agents 
with mutagenic or carcinogenic potential. 
SCE is difficult to understand on the molecular 
level, and several theories have been advanced to explain 
its mechanism. A number of these have proposed that sister 
chromatid exchange is a means of replication bypass that 
enables the DNA replication process to bypass any lesions or 
their repair intermediates that might otherwise inhibit or 
interrupt replication (Shafer 1977, 1982). Parental DNA 
strand incisions may occur via direct DNA crosslinks, 
single-strand breaks, and endonuclease incision. According 
to these models, SCE induction is linked to the bypass of 
these DNA lesions at the replication forks and, thus, is 
related to a cell's repair capacity. Ishii and Bender 
(1900) have put forth a "replication-detour model'' which 
suggests that SCE occurs at the replication fork, but is due 
to reduced chain elongation or fork displacement rate. The 
most acceptable model to date is the Painter model (Painter 
1980) which is based on the premise that double-strand 
breaks (one in each parental strand) occur frequently at the 
junctions of adjacent replicons during replication   his 
model is supported by recent evidence of DNA topoisomerases 
that can unwind DNA by making and rejoining such double- 
strand breaks (Stetka 1982: Cleaver 1983). According to the 
model, a reduction in fork displacement rates should result 
in a situation in which four free termini from a completely 
replicated replicon cluster meet and oppose two termini of a 
non-replicated cluster. SCE would occur when the daughter 
strands of the duplicated cluster combine with the opposing 
cluster's parental strands of the same polarity. It 
accurately predicts that agents which reduce far k 
displacement rates such as MMe and W light should 
efficiently induce SCE's sand that a disorder such as B ~ Q Q ~  
Syndrome, which has a fork displacement rate 30% below 
normal, should have a high SCE frequency (Stetka 1982). 
Growth of cells in culture. Mammalian cells 
culture exhibit much the same classical growth kinetics as 
microorganisms (Paul 1975). When cells are taken from a 
stationary culture, there is at first a "lag" phase before 
growth commences. During this phase, there is generally 
little increase in cell number. It is, rather, a period of 
adaptation during which the cell replaces elements of the 
glycocalyx lost during trypsinization, attaches to the 
surface of the culture flask, and spreads out. It is during 
this lag phase that DNA and pr0tei.n synthesis are 
initiated. Following this, growth of the culture proceeds 
steadily in what is known as the "logarithmic". or ''logWt 
phase, when cell number increases exponentially. During 
this stage, the population doubling time, the time it takes 
for a culture to increase two-fold, can be determined 
(Freshney 1983). The length of the log phase can vary, 
depending on the seeding density, the growth rate of the 
particular cell strain, the density at which cell 
proliferation is inhibited for a particular strain, the 
availability of nutrients, pH, and temperature. ~uring this 
time of proliferation, normal cells have an absolute demand 
for growth factors, provided in animal serum or otherwise, 
and will divide as long as free space is available and the 
growth factors are provided (Rudland et al, 1974; Westerrnark 
and Wasteson 1975)- Toward the end of the log phase, the 
culture becomes confluent, when a11 available growth surface 
is occupied and all cells a r e  in contact with surrounding 
cells. At this point, the growth rate of the culture is 
reduced and may cease. Entering what is known as the 
"stationary" or "plateau" phase, cells become less motile 
and may align themselves in parallel rows. 
Cell growth kinetics have been used to compare 
differences in cell lines and differences in the responses 
of cell lines to various nutrients and other medium 
components. Such measurements include cell cycle time. 
plateau level, doubling time, and the mitotic index. 
Measurement of cell cycle time often employs radioactive 
labeling to measure cell transit through one generation 
until its return to the same point in the cycle. The 
plateau level* the cell concentration at the plateau phase, 
is dependent on the cell type and the frequency of medium 
replenishment, but is difficult to measure accurately as a 
steady state. The measurement of the population doubling 
time is used to quantify the response of cells to different 
inhibitory or stirnulatory culture conditions (Freshney 
1983). Mitotic index, the percentage of cells in mitosis as 
a proportion of the whole population, is used as a measure 
of cell proliferation. 
Fibroblast qrowth factor, Discovered by 
Gospodarowicz (1974) , fibroblast growth factor (FGF) is a 
polypeptide isolated from the bovine pituitary and brain 
which enhances the proliferation of fibroblastic cells in 
monolayer culture (Xatoh and Takayama 1984). FGF has been 
shown to provoke a resumption of growth in density-inhibited 
fibroblast cultures (Gospodarawicz et al. 1976) and to act 
as a mitogen for early passage human fibroblast cultures in 
the presence of low serum or no serum at all. In high 
concentration of serum (10% or greater) FGF was shown to 
have an additive effect over serum (Gospodarowicz et al. 
1976). Gospodarowicz and Moran (1975) showed that FGF in 
culture medium with serum reduced the division time of human 
fibroblast cultures from two days to one day, w i t h  a final 
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cell density 3 . 3  times greater than that observed using 
optimal serum concentration alone. Pituitary FGF has been 
shown to be active at concentrations as low as 0.25 ng/ml 
when used to culture human endothelial cells (Gospodarowicz 
et al. 1983). gatoh and Takayarna (1984) found FGF, in 
conjunction with 5% fetal calf serum, to stimulate human 
dermal fibroblasts dose-dependently at up to 200 ng/ml. 
Gospodarowicz and Moran (1975) tested the effect of FGF on 
slow-growing cells. When skin fibroblasts from patients 
with cystic fibrosis, whose cultured fibroblasts grow much 
more slowly than those from normal individuals, were grown 
in the presence of FGF with 10% fetal calf serum, FGF was 
shown to decrease their doubling time by 30-50%- 
Bloom Syndrome: Two diagnosed cases, ~n central 
Iowa two brothers have been diagnosed as having Bloom 
Syndrome. Born to unrelated, non-Jewish parents, the 
brothers, ages 6 and 7, have been diagnosed by physicians at 
three separate medical facilities based on their clinical 
symptoms. KB, the older of the two boys and the object of 
this study, was born July 14, 1977, at full term with low 
birth weight dwarfism (2430 g). He has continued this 
dwarfism with normal body proportions. He is photosensitive 
and displays the telangiectatic erythema. or typical 
"butterflyw facial rash associated with 8s. Since birth, h e  
has shown a predisposition to infections, an ill'klllunological 
feature of the disorder. In addition to these features. he 
exhibits dolichocephaly (elongated facial appearance), 
micrognathia (small jaw), clinodactyly (deflection of the 
fingers), and shows some livedo reticularis (a reddish-blue 
netlike mottling of the extremities). Be has small, light- 
colored eyelashes, and a severe enamel defect of the 
teeth. There is no sign of mental retardation. 
While the clinical features strongly support the 
diagnosis of Bloom Syndrome, the cytogenetic features fail 
to comply. The chromosomes from PHA-stimulated lymphocytes 
have been examined for both boys and show neither an 
increased frequency of sister chromatid exchange nor 
increased breakage. This lack of characteristic cytogenetic 
evidence to support the diagnosis could indicate genetic 
heterogeneity in Bloom Syndrome, Heterogeneity occurs when 
homozygosity at a single locus is able to produce an array 
of abnormalities that are recognized clinically as a single 
syndrome (German 1983b) or when mutations at different loci 
act independently to produce traits that are difficult to 
distinguish clinically (Thompson and Thompson 1980). 
Genetic heterogeneity is undocumented in Bloom Syndrome, 
although there has been a report of a previous diagnosis of 
BS in a Japanese child who had the clinical features of the 
disorder but a normal frequency of spontaneous chromosome 
aberrations (Arase et al. 1980). The report has also been 
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made of a patient with the cytogenetic features of Bloom 
syndrome but without a history of sun-sensitivity (Uchiya 
et al. 19791. If the fibroblasts of the boys in question 
are shown to have an elevated frequency of spontaneous 
chromosome aberrations, this would lend support to the 
diagnosis and would be of interest in the establishment of a 
Bloom Syndrome variant. 
The purpose of this study was to measure the sister 
chromatid exchange level in the fibroblasts of the diagnosed 
Bloom syndrome patient, KB, and to compare it with the SCE 
levels in the skin fibroblasts of a confirmed Bloom Syndrome 
individual and a normal individual, R comparison was also 
made of the mitotic indices of the three cell lines. The 
study further investigated the growth response of the dermal 
fibroblasts of the KB patient, a known Bloom Syndrome 
control, and a normal control to various concentrations of 
fibroblast growth factor, administered in conjunction with 
either high or low concentrations of fetal calf serum, 
Growth response was measured in terms of population doubling 
time and maximum cell concentration attained. 
METRODS AND MATERIALS 
Cell lines. Dermal tissues from KB and the normal 
control, CS, were obtained by skin punch biopsies. T h e s e  
tissues were grown as primary explants to develop 
fibroblastic monolayer cultures. Control Bloom Syndrome 
dermal fibroblasts (GM2548A) were obtained from the MIGNS 
Human Genetic Mutant Cell Repository (Camden, New Jersey). 
Culture conditions. All cell lines were routinely 
maintained in Eagle's minimal essential medium (1UIEM) (D- 
medium, Gibco) or Dulbecco's modified MEM (DME, Gibco) 
supplemented with 20% fetal bovine serum (Byclone) . Either 
gentamycin sulfate (50 ug/ml) (Sigma) or 
penicillin/streptomycin (100 units/100 ug/ml) (Gibco) was 
added as an antibiotic. Cells were maintained in plastic 
tissue culture flasks (Corning, 25 cm2 or 75 cm2) at 3 7 O ~  in 
a 5% C02  atmosphere. Media was replaced twice a week. 
Cells were routinely passaged when they reached 
con£ fuence. For passage or harvest, cells were washed with 
versene (0,02% EDTA in Puck's saline A), then removed from 
the surfaces of the culture flasks with 0,04% trypsin 
(Difco) in versene. 
Growth response to fibrobfast qrowth f ac to r .  TO 
determine the growth response of each cell line to 
fibroblast growth factor, fetal bovine serum, and these two 
growth supplements in combination, cells were cultured in 
medium supplemented with either high fetal bovine serum 
(20%) or minimal fetal bovine serum ( 0 . 5 % ) ,  and three 
concentrations of bovine pituitary FGF (0.1 nq/ml; 1.0 
ng/ml; and 10.0 ng/ml) (Sigma) . Final working 
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concentrations of FGF were obtained from dilutions of an FGP 
stock solution (100 ng/ml) . 
Cells from each of the cell lines (KB, CS, GM2548A) 
were seeded in eight sets of 25 cm2 culture flasks 
(4  flasks/set) at a cell density of 1 x lo6 cells/ml in 5 ml 
culture medium. FBS and/or FGF was added at the initial 
seeding (Day 0) as follows: 
Set of Culture Flasks Growth Supplement 
Control 
20% FBS 
20% FBS, 0.1 ng/rnl FGF 
20 % FBS , 1,O ng/rnl FGF 
20% FBS, 10.0 ng/ml FGF 
0.5% FBS, 0.1 ng/ml PGF 
0,5% FBS, 1.0 ng/ml FCF 
0.5% FBS, 10.0 ng/ml FGF 
Fresh FGF was added daily to those flasks still in 
culture. Medium (with the appropriate serum concentrations) 
was replaced every other day (Days 2, 4, and 6) . 
Growth response was measured as the number of 
cells/ml over a seven-day period using a Caulter counter. 
For each cell line, the cell concentration in a flask with 
each of the eight treatments (A-A) was measured every other 
day (Days 1, 3 ,  5, and 7). Each of two samples from a flask 
was counted twice and these figures were averaged to 
deternine number of cells/ml. Cell concentrations were 
plotted versus time in days to establish growth curves for 
the different growth supplement conditions. 
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Sister chromatid exchange analysis. Cells from each 
cell line were seeded in 25 cm2 culture flasks at 
approximately 1 x cells/ml in LO ml DME medium 
supplemented with 20% fetal bovine serum and 
penicillin/stre~tom~cin (100 units/100 ug/ml) , 0.1 ml 
lom2 M 5-bromo-2' -deoxyur idine (BrdU) (Sigma) was added to 
each flask for a final BrdU concentration of 30 ug/ml, 
Flasks were incubated at 37OC in a 5% C02 atmosphere. At 24 
hours, both medium and BrdU were ~eplaced. At 68 hours, 
colcemid (1 ug/ml) (Gibco) was added to block dividing cells 
i n  metaphase, and at 72 hours, cells were harvested, 
harvest, cells were washed once with versene, then removed 
from the culture flask with 0.04% trypsin (Difeo) in 
versene. Cells were suspended in fresh medium supplemented 
with 10% FBS to halt the action of the trypsin, and all 
culture fluids were combined in a 15 ml conical centrifuge 
tube, Cells were concentrated by centrifugation at 1000 rpm 
for 6 minutes, then treated with 10 ml 0.075 M KC1 hypotonic 
solution for 10 minutes. Cells were fixed in Carnoyts 
fixative (3 methanol:l glacial acetic acid) for 20 minutes. 
then stored overnight in fixative at ~ O C .  
Slides were made by dropping a concentrated cell 
suspension on a cold, wet slide which was then passed 
through a flame to dry. Slides were examined with a Zeiss 
photomicroscope 11 using phase contrast, and those slides 
with metaphase spreads were aged at 60°c overnight. 
To stain for chromatid differentiation and sister 
chromatid exchange analysis, slides were placed in a coplin 
jar containing a solution of the bisbenzimidazole dye 
Hoechst 33258 ( 5  ug/ml) in Sorenson's buffer, pEI 6.8, for 15 
minutes, washed in distilled water, then mounted in 
Sorenson's buffer, pH 8.0. Mounted slides were exposed to a 
high-intensity W light at a distance of approximately 10 cm 
for 1-1/2 hours. Following this exposure, coverslips were 
removed and slides were washed in distilled water, then 
stained in 5% Giemsa solution (Gurr's R66) in Sorenson's 
buffer, pH 6 , 8 ,  for 30 minutes, 
Slides wese examined with a Zeiss photomicroscope 
IT. Metaphases exhibiting good differential staining and 
little or no overlap of chromosomes were considered 
acceptable for scoring of sister chromatid exchanges. Under 
oil immersion at 1250X, interchange points, as evidenced by 
differences in staining intensity along the chromatids, were 
counted. Each exchange point was counted as an SCE, rather 
than the area between exchange points. 
Mitotic index. The mitotic index for each cell line 
was determined by counting the number of cells in division 
per 1000 cells from the slides prepared for sister chromatid 
exchange analysis. 
Growth ==Ponse of fibroblasts to growth supplement 
FGF. The growth responses of the fibroblastic cell lines 
-
KB, CS (normal fibroblasts) , and GM2548A (Bloom Syndrome 
fibroblasts) to various concentrations of fibroblast growth 
factor with both high and low levels of fetal bovine serum 
were measured two ways, First, population doubling time, 
the time required for the number of cells in culture to 
increase by a factor of two, was used to compare growth 
rates among the cell lines. Second, maximum cell 
concentrations attained over the seven-day culture period by 
each cell Line were compared. 
Figures 1-8 show the growth curves of the 
fibroblastic cell lines (KB, CS, and GM2548A) under each of 
the eight different culture conditions (A-H). The curves 
are semi-logarithmic curves, i,e., the numbers of cells/ml 
are plotted on a logarithmic scale versus time on an 
arithmetic scale. This type of growth curve has the 
advantage of minimizing counting errors and furthers the 
possibility that population doubling time can be expressed 
as a function of the slope of the straight-line portion of 
the curve. Cell counts were made by taking 0.5 ml of a 
l:500 dilution from a 5.0 ml cell suspension. This required 
that Coulter counter readings be multiplied by 5,000 to 
achieve a final determination of number of cells/ml in the 
Culture! T i m e  mays) 
F i g u r e  1. F i b r o b l a s t  g rowth  cur re ,  Treatment A,  C o n t r o l  (no 
growth supplement) . 
Culture Time CDaysl 
F i g u r e  2 .  F i b r o b l a s ~  g rowth  curve, Treatnent B ,  G r o w t h  supplement:  
20% f e t a l  bovine serum. 
Culture Time (Days) 
Figure  3 .  F i b r o b l a s t  growth CUTYE, Treatment  C , G r o w t h  supplements  : 
20% f e t a l  bovine se-, 0.1 ng/ml f i b r o b l a s t  growth f a c t o r .  
Culture T h e  (Days1 
Figure 4. Fibroblast growth cume. Treatment D, Growth supplements: 
20% fecal bovine serum, 1.0 n g / d  fibroblast g r o w t h  factor. 
Culture T i m e  (Days) 
Figure 5. Fibroblast growth curve,  Treatment  E, Growth supplements: 
20% fetal bovine serum, 10.0 ng/ml fibroblast g r o w t h  f a c t o r .  
Culture T i n e  [Days) 
Figure  6 .  Fib rob l a s t  growth curve, Treatment F, Growth Supplements: 
0.5% fetal bovine serum, 0.1 n g / d  fibroblast growth f a c t o r .  
C u l t u r e  T h e  (Days] 
F i g u r e  7 .  F i b r o b l a s t  g rowth  curve, Treatment  G , Growth supplements : 
0.5% feral bovine serum, 1 . 0  ng/ml fibroblast growth  factor. 
Culture Time  CDays) 
Figure 8. B i b r o b l a s t  growth curve, Treatment H ,  Growth supplements: 
0.5% fe ta l  bovine serum, 10.0 ng/ml f i b r o b l a s t  growth  f a c t o r .  
flask being counted. 
population doubling time, also called "generation 
time" was determined for each cell line during the first 48 
hours of growth. This time interval was chosen so that 
comparisons of the cell lines could be made between 
treatments as well as within a treatment. As a population 
did not always double during this period of time, a growth 
rate constant ( p )  for each cell line at each treatment level 
was calculated. This growth rate constant is a 
proportionality constant that can serve as an index of a 
culture's rate of growth. It is determined by using the 
formula, 
where p = the growth rate constant, N = the number of 
cells/ml, and t = time. The relationship between P and the 
population doubling time (g) for a culture is expressed by 
the formula, 
The values for the proportionality constant f ) and the 
Population doubling time (g) Ear each cell line under each 
O f  the eight treatments are liste? in Table 1. 
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Table 1. Population Doubling Times and Growth  Rate Constants wing 
the First 48 Bwrs of Culture at  Different G r o w t h  Supplement 
Levels 
Cell Line 
1-1 = Growth rate constant 
g = Population doublirrj time (in days) 
~aximum cell concentrations reached by each of the 
cell lines under each of the growth supplement treatments 
over the seven-day culture period are listed in Table 2. 
This maximum level of cells/ml cannot be described as a 
"plateau" level for all cell lines. In some cases, a 
plateau level was reached and maintained, but in others the 
culture reached a peak level, then declined. Figure 9 shows 
plots of the maximum cell concentrations for each cell line 
in response to tenfold increases in FGP at a high serum 
level (20% FBS) .  Figure 10 shows plots of the maximum cell 
concentrations in response to tenfold increased in FGF at a 
low serum level (0.5% FBS) . 
Mitotic index. The mitotic index was determined for 
each cell line on the basis of number of cells in metaphase 
division per 1,000 cells counted on the slides prepared for 
sister chromatid exchange analysis. An average mitotic 
index was determined from five separate counts. These 
results are reported in Table 3. 
Sister chromatid excbanqe analysis. Cells from each 
cell line were cultured for 7 2  hours in DME medium 
containing BrdU (30 pg/ml)  supplemented with 20% fetal 
bovine serum and penicillin/streptomycin (100 U/100 ug/rnl). 
then harvesteda Slides were prepared and stained for sister 
chromatid exchange analysis. The counts of these sister 
chromatid exchanges for each cell line are recorded in 
Table 2. Maximum Concentrations a t  Different  Growth  ~upp3ement 
Levels. 
Maximum Cel l  Goncentrat im (ceUs/nrl. x lo6) 
Treatment, 
Growth Supplement ECB CS C;M2548A 
A, Control (No FBS, No EGF') 7.50 6.35 4.08 
Q 
FGF G b g / d l  
Figure 9. Maam cell  concentrations w i t h  t e n f o l d  irk~n2a~es of 
FGF (20% FBS) . 
Figure  10. laximum cell concentraCions w i t h  tenfold increases 
of FGF CO. 5% FBS) . 
T a b l e  3. Average Mitotic Index.  
C e l l  L i n e  C e l l s  i n  D i v i s i o n / 1 0 0 0  C e l l s  
T a b l e  4 .  S i s t e r  C h r o m a t i d  E x c h a n g e  L e v e l s ,  
C e l l  Number of R a n g e  of S t a n d a r d  
L i n e  C e l l s  SCE's M e a n  SCE E r r o r  
CS 1 0  4 - 1 7  8.89 + 0.40 
Table 4. The normal cell line, CS, yielded the most 
metaphases for analysis, with respect to both chromosome 
spreading and chromatid differentiation. Ten complete cells 
from this line were chosen for SCE analysis. Neither the 
Bloom Syndrome cell line, GM2548A, nor the KB cell line 
yielded as many comparable metaphase spreads. Often the 
chromosome spreads were incomplete, involved many overlaps, 
were too contracted, or were first-division metaphases, 
making them unsuitable for analysis. For these reasons, as 
well as lower mitotic indices for these lines compared with 
the CS line, fewer cells in these lines were used for sister 
chromatid exchange analysis, 
DISCUSSION 
Growth response to FGF. Population doubling time 
(Table 1). Measurement of population doubling times during 
the first 48 hours of culture showed all three cell lines to 
exhibit similar rates of growth under the control 
conditions. When cultured in medium without the addition of 
any growth supplements (Treatment A ) ,  all three lines 
doubled their populations in slightly over one day, the 
normal cells (12s) responding a little more slowly (1.13 
days) than the RB and GM2548A lines. When cultured in 
medium supplemented with 20% FBS (no FGF. Treatment B ) r  all 
three lines doubled their populations in just under one 
day's time, the normal cells (CS) responding slightly better 
( 0 . 8 4  days) to the addition of serum. 
When FGF, in tenfold increases, was added to medium 
with 20% FBS (Treatments C, D, and E), some differences in 
the growth rates emerged. At the lowest concentration of 
FGF (0.1 ng/ml, Treatment C), the RB cells were the slowest 
responders, doubling their population in 1.3 days. The 
Bloom Syndrome cells (GM2548A) responded best (0.87 days) at 
this level, although their rate of growth was approximately 
the same as that seen in Treatment B (no FGF). The normal 
cell line (CS) doubled its population in just under one day 
(0.99 days) . Thus, this level of FGF cannot be said to 
enhance the growth of any of the cell lines and it appears 
to have retarded the growth of the KB line slightly. These 
results support the findings of Gospodaro~ic~ et ale (1983) 
in which pituitary FGF in medium supplemented with 20% fetal 
bovine serum was not active below the level of 0 .25  ng/rnl. 
Treatment D (1.0 ng/ml FGF) produced population doubling 
rates similar to those of the control treatments in both the 
KB and C S  cell lines, but retarded the growth in the GM2548A 
cell line (1.62 days). In spite of this, GM2548A was shown 
to have the highest cell concentration of the three lines 
Over the culture period (Figure 4 )  . The highest 
concentration of FGF at 20% serum (10.0 ng/ml. Treatment E )  
again showed a population doubling time of just under one 
day for the normal cell line. 
Thus, it appears that the 
normal fibroblasts were unaffected by the addition of FGF at 
any of the three concentrations tested in the presence of a 
high level of serum. Some reduction in population doubling 
time was expected, as Gospodarowicz and Moran (1975) found 
that FGF at a concentration of 25 ng/ml in medium with 20% 
FBS reduced the population doubling time of normal human 
fibroblasts by half. It is possible that a concentration of 
10 ng/mL FGF was too low for this effect to be seen, or that 
the GS cells used the growth factors in the serum 
preferentially, not utilizing the purified FGF. The KB 
cells showed the lowest generation time (0.81 days) under 
Treatment E, 13% lower than the generation time in the 
culture with 20% serum alone. Thus, at this treatment 
level, the RB line demonstrated a positive growth response 
to FGF, with an additive effect of the serum and FGF 
suggested. The GM2548A cell line had a population doubling 
time of 1.13 days with Treatment E, a slight retardation of 
the growth rate. This line, however, again had the highest 
cell concentration overall Eor this treatment (Figure 5). 
It would appear that the addition of 1.0 ng/ml and 10.0 
ng/ml amounts of FGF to medium with 20% FBS had the effect 
of slightly retarding the initial ge"erati0n time in this 
Bloom Syndrome cell line. This lengthening of the lag time 
Could reflect a period of adjustment by these cells in 
preparation for their eventual utilization of the FGF. 
~ a m a l i a n  cells in tissue culture have been shown to 
require serum for growth and when serum is absent or present 
at low concentrations ( < 1%) , growth is limited 
(~ospodarowicz and Moran 1975). The growth-promoting 
factors in serum remain mostly unidentified, but there has 
been some evidence that steroids and polypeptides in serum 
are required Components (Gospodarowicz and Moran 1975) . The 
singular effect of the polypeptide FGF can, thus, best be 
tested by its addition to cultures in the presence of a 
minimal amount of serum. When FGF was added, in tenfold 
increases, to medium containing only 0 . 5 %  FBS (Treatments F ,  
G, and H), the results in terms of population doubling time 
were mixed, The data show that all three concentrations of 
FGF in medium with low serum enabled of the KB and 
CS fines to maintain or reduce their generation times 
relative to those seen in cultures with 20% serum (Treatment 
B ) .  Despite the fact that these lines showed only a small 
Serum response, their generation times at a 20% serum 
Concentration being just slightly under the control (no 
serum, no FGF) generation times, the data suggest that RB 
and CS cells were able to utilize FGF effectively for 
growth. In the normal cell line ( C S ) ,  FGF was able to 
reduce the population doubling times at two of the treatment 
levels (0.1 ng/ml and 10.0 nq/ml) below those seen at t h e  
20% FBS levels, and in the KB line, a reduction was seen at 
one treatment level (1.0 ng/rnl) . Even though these 
generation time reductions were not seen uniformly in each 
line, they still suggest that FGF, by itself, could enhance 
the population doubling rates of CS and KB. It is possible 
that these cells were best able to use this growth 
supplement in its purified form. The Bloom Syndrome cell 
line (GM2548A) exhibited retardation of the population 
doubling time (1.48 days) in response to FGF at 10.0 ng/ml 
with low serum, and doubling times similar to the control 
(Treatment A) rate at the other two FGP Levels. Taken by 
itself, this effect would possibly indicate a serum- 
dependence of the line. The fact that growth retardation 
was seen at both high and low serum levels, however, and 
especially at the higher concentrations of FGF, suggests a 
growth-delaying action of FGF with respect to this cell 
line. The effect cannot be called inhibitory because each 
of the growth-retarded cultures ultimately achieved the 
highest cell concentration for that particular treatment 
(Table 2). The delayed initial growth could be due to the 
cellsf need to switch to an alternate pathway for the 
utilization of purified FGF. Also, because G ~ 2 5 4 8 A  was a 
l ~ n g e r - ~ a ~ ~ ~ ~ ~  cell line compared with the other two cell 
lines, it is possible that cell selection had occurred so as 
to create a seeum-preference in t h a  line, if not a 
serum-dependence. 
It should be noted that slight retardations or 
of the generation times seen in any of the cell 
lines at a particular treatment level could be due to chance 
variations. Such variations could result from counting 
errors or differences in the initial cell densities of the 
flasks. Repeated measurements of each cell population using 
a coulter counter tend to minimize these potential sources 
of error. 
Growth response to FGF, Maximum cell 
concentrations. The maximum cell concentrations reached 
over the seven-day culture period by the three cell lines 
reveal patterns of growth response to fibroblast growth 
factor (Table 2). The Bloom Syndrome cell line (GM2548A) 
exhibited a progressive response to increasing levels of 
FGF, at both high and low FBS concentrations in the 
medium. The maximum cell concentration for this line 
increased 27% over that seen a t  t h e  control level (Treatment 
A )  upon the addition of 20% FBS (Treatment B). Increasing 
amounts of FGF in conjunction with this level of serum led 
to corresponding increases in maximum cell concentrations. 
At 1.0 ng/rnl and 10.0 ng/ml FGF, the Bloom Syndrome line 
responded with maximum cell levels more than two times that 
seen with 20% serum alone. A low serum level (0.5% FBS) 
with a minimal amount of FGF (0.1 ng/ml) produced no growth 
in G~2548A above that of the control (Treatment A )  level. 
The  two higher concentrations of FGF at low serum. however. 
produced corresponding changes in maximum cell levels. 
At 
1.0 ng/ml and 0.5% FBS, the culture reached a cell maximum 
two time5 greater than that of the control (Treatment A )  
level, and at 10.0 ng/ml FGF and 0.5% FBS, the level was 
four times that of the control. These data demonstrate that 
the Bloom Syndrome cells were sensitive to fetal bovine 
serum and fibroblast growth factor both singly and in 
combination with respect to maximum cell concentration, with 
the greatest effect being seen at the highest level of FGF 
at both serum concentrations. 
The normal cell line (CS) also displayed a growth 
response to FGF. Control and 20% FBS cultures (Treatments A 
and B )  produced similar maximum cell concentrations, 
indicating a lack of serum dependency for the line. The 
addition of FGF to medium with 20% serum resulted in 
Successive increases in the maximum cell concentrations, 
though the increase between the 1.0 ng/ml and 10.0 ng/ml FGF 
levels was slight. This suggests that the cell line had 
reached a plateau level of response to FGF, an idea which is 
supported by the research of ~ospodarowicz et al. (1983). 
In testing the effect of FGF on human endothelial cells. 
these researchers found bovine pituitary FGF in medium with 
20% Serum to be saturating in its effect at 2.5 ng/ml. 
~lthough the data from Treatments A and B imply that CS has 
a minimal serum response, a slightly additive effect was 
seen with the addition of FGF to medium with 20% serum. 
In 
 onj junction with low serum. the additions of all three 
  on cent rations of FGF produced maximum cell concentrations 
in the CS culture equal to or higher than that seen at 0.1 
*g/ml and a high serum level, and surpassing that seen with 
20% serum alone. These growth responses suggest that the CS 
Line is sensitive to fibroblast growth factor, alone. 
The KB cell line responded to FGF plus 20% FBS in a 
manner similar to that of the normal control line, although 
the response was uniformly weaker. Like CS, the KB line 
exhibited similar maximum cell concentrations with both 
Treatments R and B, the cells responding slightly and 
inexplicably better to the medium lacking serum. ~ i k e  CS, 
this implies a lack of serum dependency. The addition of 
FGF to medium w i t h  20% serum elicited a growth response in 
KB at the 1.0 ng/ml and 10.0 ng/ml levels. Again, these 
maximum cell concentrations were shown to reach a plateau, 
although at a lower level than that attained by the CS 
cells. Still, the maximum cell concentration at this 
plateau level was 1.5 times the maximum concentration 
achieved by the culture with 20% Serum alone, showing that- 
FGF with high serum did have a growth stimulating effect on 
this line. too.  his growth response at the two highest FGF 
levels in medium with 20% serum imply a slight additive 
effect of the growth suP~lement~, the two having to work in 
combination to effect a growth increase. 
The maximum cell 
concentrations seen when FGF was added in conjunction with 
0.5% FBS, however, pointed up a difference between this cell 
line and the others. At 0.1 ng/ml and 10.0 ng/ml FGF, the 
maximum cell concentrations fell below that of the control 
level (Treatment A), while at 1.0 ng/ml FGF, the maximum 
cell concentration was comparable to the control level. 
These data show that FGF by itself did not stimulate growth 
of the KB cell line, This could be due to a lack of cell 
machinery able to effectively utilize FGF by itself, or in 
its purified form. 
In measuring the effects of FGF on early passage 
human fibroblasts, GospoWowicz and Moran (1975) found that 
FGF at 10.0 ng/ml stimulated DNA synthesis as effectively as 
did an optimal amount of serum. Using this as a point of 
comparison, the CS cell line was seen to support this 
finding, utilizing 10.0 ng/ml FGF even a little more 
effectively for growth than it did the 20% serum. The Bloom 
Syndrome cell line surpassed this expectation, nearly 
tripling the maximal growth level of the 20% serum 
treatment. The KB cells, on the other hand, did not exhibit 
this response and could even be termed "defectivete in their 
ability to utilize FCF. 
~igures 9 and 10 compare the responses of the three 
cell lines to E'GE' with high and low serum levels, 
respectively* Figure 9, the plot of the maximum cell 
attained with FGP in medium with 20% FBS, 
demonstrates that GM2548A was the cell line to respond most 
positively to FGF, CS gave the second best response, and the 
response of KB was the weakest. All three cell lines 
attained a plateau level of growth between the 1.0 ng/ml and 
10.0 ng/ml concentrations of FGF, supporting the findings of 
Gospodarowicz et al. (1983) relative to a saturation effect 
of FGF. Figure 10, the plot of the maximum cell 
concentrations attained with FGF in medium with 0 .5% FBS, 
shows the strong growth response of the GM2548A line to FGF 
alone, the intermediate response of the CS Line, and the 
non-response of the KB line. The CS line again seemed to 
reach a plateau between 1.0 ng/ml and 10.0 ng/ml FGF 
concentrations, but the GE12548A line exhibited a steady 
increase in growth between these two levels. The KB line 
showed a general decline in growth* It is possible that, 
because the Bloom Syndrome line was a late-passage cell 
line, cell selection had taken place to the point where 
those cells best able to respond to the addition of FGF had 
been retained, resulting in a more homogeneous and better- 
responding population. The early-passage lines, CS and KB, 
most likely represent more heterogeneous cell populations 
which might be less able  to respond overall. 
It should be noted that the measurement of maximum 
 ell concentrations is a measure of a peak level that was 
often followed by a period of decline in each of the cell 
lines. Such a period of population decline is due to cell 
death and can result from an accumulation of acid 
by-products in the medium or contamination of the culture, 
Regular changes of the culture medium should reduce the 
accumulation of toxic ce l l  products. Visual indications of 
contamination were not present; however, hard-to-detect 
viral or mycoplasmal contamination could have been present, 
Mitotic index, Table 3 shows the normal cell line, 
CS, to have the highest average mitotic index of the three 
cell lines ( 4 t 2 . 2 4 ) .  The Bloom Syndrome cell line, GM2548A, 
had the second highest mitotic index (351.87). The KB line 
exhibited the poorest growth in terms of this measurement. 
with a mitotic index of 0.610.89. These data point up the 
much lower growth rate of the RB cell line compared with 
that seen in both normal and Bloom syndrome cells and 
support the findings of Brat (1979) * 
Sister chromatid exchange analysis. The average 
numbers of sister chromatid exchanges per metaphase for each 
cell line are listed in Table 4. These averages are based 
On sister chromatid exchanges counted in five cells for  the 
G M 2 5 4 8 ~  and KB c e l l  lines, and ten cells for the CS cell 
line. Because of incomplete metaphases , chromosome 
 rowd ding, and ov@rla~s, a smaller number of suitable 
rnetaphases Was available for analysis in the Bloom Syndrome 
and KB lines. Nevertheless, the data clearly indicate that 
the average  umber of sister chromatid exchanges in the RB 
cells (8.25'1.02) corresponds to the average number seen in 
the normal cell line (8.89q.40) and falls within the 
expected range of average values for normal cells 
(6.9 - 9.3) (Chaganti et al, 1974; German et al. 1977a). 
The Bloom Syndrome cell line exhibited an average sister 
chromatid exchange level that was predictably high (60.75' 
3 - 7 7 ]  and characteristic for Bloom Syndrome (Chaganti et al. 
These findings indicate that the KB fibroblastic cell 
line does not display the characteristic cytogenetic 
features associated with Bloom Syndrome with respect to 
sister chromatid exchange. The average number of sister 
chromatid exchanges in the KB fibroblasts and their range 
(3 -15)  correspond to similar values seen previously in the 
lymphocytes (mean, range r {James 1984, 
unpublished d a t a ) .  The differences in the means is possibly 
due to the small sample size of the fibroblastic cells. 
Thus, the sister chromatid exchange level was shown to be in 
the normal range of KB fibroblastic cells as well as for 
l~mphoc~tes, which supports previous findings of 
in t h e  sister chromatid exchange levels 
between lymphocytes and fibroblasts in both normal (Zakharov 
- 1982) and Bloom Syndrome cells (Brat 1979). 
The fact that 
the finding of two ~opulations of lymphocytes with respect 
to sister chromatid exchange levels, reported in some Bloom 
syndrome patients, has never been seen in fibroblasts 
(shiraishi et al. 1983b) suggests that the sister chromatid 
exchange level determined for the RB fibroblasts is an 
accurate representation of the patient's sister chromatid 
exchange rate. 
CONCLUSIONS 
The diagnosis of Bloom Syndrome in the KB patient is 
not supported on the basis of the growth responses and 
sister chromatid exchange rate determined for the 
fibroblastic cells. It is possible that the patient has a 
variation of Bloom Syndrome not previously reported in which 
the clinical features of the syndrome are present, but the 
cellular responses are atypical when compared to classical 
Bloom Syndrome. Variations of this sort are known £OK 
another chromosome fragility disorder, xeroderma 
pigmentosum, for which seven complementation groups have 
been reported (Witkop 1983). It is also possible that the 
case represents a disorder other than Bloom Syndrome, in 
Which case different criteria would have to be used to 
establish a prognosis for this patient. I n  particular, the 
expectation for cancer Predisposition may be reduced because 
of the normal sister chromatid exchange rate observed in 
both lymphocytes and fibroblasts. 
SUMMARY 
S his research compared features of the KB cell line 
of a patient who had been diagnosed with Bloom Syndrome with 
a known Bloom Syndrome cell line, GM2548A, and a normal 
control cell line, CS, with respect to growth response to 
fibroblast growth factor, mitotic index, and sister 
chromatid exchange rate. 
Measurements were made of population doubling time 
and maximum cell concentration produced in response to three 
levels of fibroblast growth factor in combination with high 
and low levels of fetal bovine serum. The KB cell line 
demonstrated that, like the normal cell line, it could use 
FGF for growth as measured in terms of population doubling 
time. In terms of maximum cell concentration achieved over 
the culture period, however, KB showed the weakest response 
to FGF in medium with high FBS, and no response to FGF in 
medium with low FBS. The KB cell line also showed a minimal 
response to serum in medium. With both measurements, the 
responses of the RB cells were dissimilar to t h o s e  of the 
known Bloom Syndrome cells. The mitotic index for each 
line demonstrated that the KB cell line q I e W  much Tiore 
slowly than the other two lines, as the KB mitotic index Was 
considerably lower. Analysis of sister chromatid exchange 
rates showed that the average number per metaphase for the 
KB fibroblasts was within normal values, and unlike the 
elevated rate seen in the Bloom Syndrome cells. These 
combined observations suggested that the KB fibroblastic 
cells are impaired, differing from both the normal and Bloom 
Syndrome cells with respect to growth response to fibroblast 
growth factor and mitotic index. but resembling normal cells 
with respect to sister chromatid exchange rate. 
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